Modalmed Inc. Wins Default Judgment in Eye Massager Patent Case

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

📋 Case Summary

Case NameModalmed Inc. v. The Partnerships and Unincorporated Associations Identified on Schedule A
Case Number1:24-cv-11780
CourtU.S. District Court for the Northern District of Illinois
DurationNov 15, 2024 – Jan 15, 2026 1 year 2 months
OutcomePlaintiff Win — Default Judgment & Asset Transfer
Patents at Issue
Accused ProductsHeadwear (Eye Massagers)

Case Overview

The Parties

⚖️ Plaintiff

Proprietary rights holder over headwear-integrated eye massager technology.

🛡️ Defendant

Network of anonymous or pseudonymous online retailers of infringing eye massager products.

Patents at Issue

This landmark case involved two U.S. patents covering headwear-integrated eye massager technology, a sector experiencing rapid consumer market growth. These utility patents protect the functional configurations of wearable eye care and massage devices.

  • US10684483B2 — Directed to optical or visual headwear technology with claims likely covering structural or functional configurations of eye massager devices.
  • US11372252B2 — A continuation or related patent in the same family, extending protection across additional claim configurations relevant to the accused products.
🔍

Designing a similar product?

Check if your eye massager design might infringe these or related patents before launch.

Run FTO Check →

The Verdict & Legal Analysis

Outcome

The court entered a Final Default Judgment in favor of Modalmed Inc. against the Defaulting Defendants. The judgment included a financial asset transfer order directing third-party payment providers — such as PayPal, Stripe, or marketplace payment processors — to immediately freeze and subsequently transfer funds from defendants’ financial accounts to Modalmed or its designated counsel.

Key Legal Issues

The verdict arose from an infringement action under the identified patents. Because the defendants failed to appear or respond, the court applied the legal standard for default judgment—accepting Modalmed’s well-pleaded allegations as true and determining that the claimed infringement of US10684483B2 and US11372252B2 was established. The financial remedy mechanism—ordering third-party providers to freeze and transfer funds—reflects the court’s exercise of equitable and legal authority over payment infrastructure, a tool that has become central to Schedule A enforcement strategy.

⚠️

Freedom to Operate (FTO) Analysis

This case highlights critical IP risks in therapeutic headwear design. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific risks and implications from this litigation.

  • View all related patents in this technology space
  • See which companies are most active in wearable technology patents
  • Understand claim construction patterns
📊 View Patent Landscape
⚠️
High Risk Area

Wearable eye care & therapeutic headwear design

📋
Active Patent Family

Modalmed’s asserted patents

Design-Around Options

Available for many claims

✅ Key Takeaways

For Patent Attorneys & Litigators

Default judgment combined with financial asset freeze orders is a powerful and increasingly standardized enforcement mechanism in Schedule A patent litigation.

Search related case law →

The Northern District of Illinois remains a strategically favorable venue for multi-defendant online infringement cases.

Explore precedents →

Maintaining patent families across multiple related applications strengthens coverage and enforcement flexibility.

Explore patent families →
🔒
Unlock R&D Team Recommendations
Get actionable design patent strategy steps for product teams, including FTO timing guidance and filing best practices.
FTO Timing Guidance Design-Around Strategies Supply Chain Compliance
Explore Full Analysis in PatSnap Eureka

Frequently Asked Questions

Ready to Strengthen Your Patent Strategy?

Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.

PatSnap IP Intelligence Team

Patent Research & Competitive Intelligence · PatSnap

This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.

The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.

📊 2B+ Patent Data Points 🌍 120+ Countries Covered 🏢 18,000+ Customers Worldwide ⚖️ Global Litigation Database 🔍 Primary Source Verified

References

  1. United States District Court for the Northern District of Illinois — Case 1:24-cv-11780
  2. U.S. Patent and Trademark Office — Patent US10684483B2
  3. U.S. Patent and Trademark Office — Patent US11372252B2
  4. Avek IP LLC Profile
  5. PatSnap — IP Intelligence Solutions for Law Firms

This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.

⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.